![Eric Mosbrooker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Mosbrooker
Direttore/Membro del Consiglio presso
National Pharmaceutical Council
Profilo
Eric B. Mosbrooker is currently Director at National Pharmaceutical Council since 2018.
Formerly, Mr. Mosbrooker was Chief Commercial Officer at Avidity Biosciences, Inc. from 2025 to 2026, Chief Operations Officer at Cognoa, Inc. from 2021 to 2023, Chief Commercial Officer & Senior Vice President at Astellas Gene Therapies, Inc. from 2019 to 2021, Chief Commercial Officer at Origin Biosciences, Inc. in 2018, Senior Vice President-Orphan Business Unit & GM at Horizon Therapeutics Ltd. (Ireland) from 2017 to 2018, and Senior Vice President-Americas & Asia Pacific at Raptor Pharmaceuticals, Inc. in 2016.
Education includes undergraduate studies at the University of Wisconsin.
Posizioni attive di Eric Mosbrooker
| Società | Posizione | Inizio |
|---|---|---|
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Direttore/Membro del Consiglio | 06/03/2018 |
Precedenti posizioni note di Eric Mosbrooker
| Società | Posizione | Fine |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 05/01/2024 |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Direttore operativo | 01/02/2023 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Direttore operativo | 01/12/2018 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/04/2018 |
Formazione di Eric Mosbrooker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Offers a mobile app and proprietary algorithm to enable early detection of autism | Health Services |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
